These findings underscore the apparent utility of measurement of IP-10, in particular, as an objective indicator of responsiveness to cART [33, 39, 42, 43], a contention which is in keeping with the role of this chemokine in the pathogenesis of HIV infection [43–46]. This evidence concerns the gene CXCL10 and HIV infectious disease.